TrialScience advances2017

Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.

Liuyang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.